{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:32:32Z","timestamp":1780392752314,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017692","name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["GIBHBRP24-03"],"award-info":[{"award-number":["GIBHBRP24-03"]}],"id":[{"id":"10.13039\/501100017692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017692","name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["GIBHBRP24-04"],"award-info":[{"award-number":["GIBHBRP24-04"]}],"id":[{"id":"10.13039\/501100017692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012186"],"award-info":[{"award-number":["2024A1515012186"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173745"],"award-info":[{"award-number":["82173745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22307116"],"award-info":[{"award-number":["22307116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2023372"],"award-info":[{"award-number":["2023372"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2022B1212050004"],"award-info":[{"award-number":["2022B1212050004"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A04J4520"],"award-info":[{"award-number":["2025A04J4520"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0210600"],"award-info":[{"award-number":["2022YFE0210600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFE0123700"],"award-info":[{"award-number":["2019YFE0123700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.apsb.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:42:18Z","timestamp":1755128538000},"page":"6546-6570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Key imidazolyl groups that induce phenylalanine flipping enhance the efficacy of oral BRD9 inhibitors for AML treatment"],"prefix":"10.1016","volume":"15","author":[{"given":"Zhiming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-7533","authenticated-orcid":false,"given":"Jinxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-0246","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.08.006_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.08.006_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrm.2016.143","article-title":"Functions of bromodomain-containing proteins and their roles in homeostasis and cancer","volume":"418","author":"Fujisawa","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2025.08.006_bib3","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1021\/acs.jmedchem.2c01638","article-title":"Recent advances on small-molecule bromodomain-containing histone acetyltransferase inhibitors","volume":"3","author":"Liu","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrd4286","article-title":"Targeting bromodomains: epigenetic readers of lysine acetylation","volume":"13","author":"Filippakopoulos","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.08.006_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.08.006_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41467-019-08554-x","article-title":"Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment","volume":"10","author":"Hu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.08.006_bib7","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/s41467-020-16443-x","article-title":"The bromodomain containing protein BRD9 orchestrates RAD51\u2013RAD54 complex formation and regulates homologous recombination-mediated repair","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.08.006_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1543","article-title":"Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours","volume":"14","author":"Chen","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.apsb.2025.08.006_bib9","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1093\/nar\/gkad907","article-title":"BRD9-mediated control of the TGF-\u03b2\/Activin\/Nodal pathway regulates self-renewal and differentiation of human embryonic stem cells and progression of cancer cells","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.08.006_bib10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41467-019-09891-7","article-title":"BRD9 defines a SWI\/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.08.006_bib11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.str.2015.08.004","article-title":"A subset of human bromodomains recognizes butyryllysine and crotonyllysine histone peptide modifications","volume":"23","author":"Flynn","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2025.08.006_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41556-020-0503-2","article-title":"Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis","volume":"22","author":"Park","year":"2020","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2025.08.006_bib13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","article-title":"A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation","volume":"20","author":"Michel","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2025.08.006_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.08.006_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1158\/2767-9764.CRC-23-0382","article-title":"The ncBAF complex regulates transcription in AML through H3K27ac sensing by BRD9","volume":"4","author":"Klein","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.apsb.2025.08.006_bib16","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.08.006_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115872","article-title":"Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia","volume":"262","author":"Zhang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","article-title":"Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer","volume":"601","author":"Xiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.08.006_bib19","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/0008-5472.CAN-07-6392","article-title":"Targeting the BAF57 SWI\/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity","volume":"68","author":"Link","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.08.006_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","article-title":"BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression","volume":"81","author":"Alpsoy","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.08.006_bib21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41467-023-37116-5","article-title":"BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism","volume":"14","author":"Du","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.08.006_bib22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1078-0432.CCR-22-3668","article-title":"BRD9 degradation disrupts ribosome biogenesis in multiple myeloma","volume":"29","author":"Kurata","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.08.006_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41305","article-title":"Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma","volume":"7","author":"Brien","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2025.08.006_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/humu.20730","article-title":"Frequent BRG1\/SMARCA4\u2013inactivating mutations in human lung cancer cell lines","volume":"29","author":"Medina","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.apsb.2025.08.006_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2019.01.007","article-title":"miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9","volume":"446","author":"Huang","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.08.006_bib26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/cancers11111634","article-title":"PIK3CA cooperates with KRAS to promote MYC activity and tumorigenesis via the bromodomain protein BRD9","volume":"11","author":"Bell","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2025.08.006_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1476-4598-7-58","article-title":"Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha","volume":"7","author":"Scotto","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2025.08.006_bib28","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.26540","article-title":"Identification of driver genes in hepatocellular carcinoma by exome sequencing","volume":"58","author":"Cleary","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.08.006_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166983","article-title":"BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma","volume":"1870","author":"Hip\u00f3lito","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2025.08.006_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2023.09.021","article-title":"BRD9\u2013SMAD2\/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma","volume":"166","author":"Feng","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2025.08.006_bib31","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3390\/cells11142160","article-title":"The functional role and regulatory mechanism of bromodomain-containing protein 9 in human uterine leiomyosarcoma","volume":"11","author":"Yang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2025.08.006_bib32","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/cam4.4954","article-title":"BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma","volume":"12","author":"Zhu","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.apsb.2025.08.006_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19648-w","article-title":"Ultra-rare BRD9 loss-of-function variants limit the antiviral action of interferon","volume":"12","author":"Mair","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.08.006_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/acsmedchemlett.1c00658","article-title":"Novel compounds for targeted degradation of BRD9 and their use for treating cancer","volume":"1","author":"Sabnis","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2025.08.006_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41419-021-04186-6","article-title":"BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors","volume":"12","author":"Mu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2025.08.006_bib36","article-title":"Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.08.006_bib37","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1038\/s41467-023-44081-6","article-title":"BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.08.006_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123428","article-title":"Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): its therapeutic potential and selective inhibition","volume":"230","author":"Ali","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2025.08.006_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41408-022-00704-7","article-title":"BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma","volume":"12","author":"Weisberg","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.apsb.2025.08.006_bib40","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.21037\/tcr-21-42","article-title":"Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells","volume":"10","author":"Zhou","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.apsb.2025.08.006_bib41","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.2147\/OTT.S286867","article-title":"Targeting BRD9 for cancer treatment: a new strategy","volume":"13","author":"Zhu","year":"2020","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.apsb.2025.08.006_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41419-019-1570-9","article-title":"BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition","volume":"10","author":"Del Gaudio","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2025.08.006_bib43","unstructured":"https:\/\/www.thesgc.org\/chemical-probes\/TP-472."},{"key":"10.1016\/j.apsb.2025.08.006_bib44","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1002\/ange.201501394","article-title":"LP99: discovery and synthesis of the first selective BRD7\/9 bromodomain inhibitor","volume":"54","author":"Clark","year":"2015","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2025.08.006_bib45","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1039\/C5MD00152H","article-title":"Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains","volume":"7","author":"Hay","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.apsb.2025.08.006_bib46","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/acs.jmedchem.5b00256","article-title":"Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition","volume":"59","author":"Theodoulou","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib47","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.jmedchem.5b01865","article-title":"Structure-based design of an in vivo active selective BRD9 inhibitor","volume":"59","author":"Martin","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib48","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/j.bmcl.2017.05.063","article-title":"Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance","volume":"27","author":"Crawford","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2025.08.006_bib49","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bmc.2019.02.045","article-title":"Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors","volume":"27","author":"Zheng","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib50","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1021\/acs.jmedchem.0c00478","article-title":"4-Acyl pyrroles as dual BET-BRD7\/9 bromodomain inhibitors address BETi insensitive human cancer cell lines","volume":"63","author":"H\u00fcgle","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105480","article-title":"Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders","volume":"118","author":"Pierri","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115139","article-title":"A novel pan-selective bromodomain inhibitor for epigenetic drug design","volume":"249","author":"Warstat","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115018","article-title":"Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders","volume":"247","author":"Colarusso","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113513","article-title":"Identification of selective BRD9 inhibitor via integrated computational approach","volume":"23","author":"Ali","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.08.006_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202200868","article-title":"6-Methylquinazolin-4(3H)-one based compounds as BRD9 epigenetic reader binders: a rational combination of in silico studies and chemical synthesis","volume":"2022","author":"Colarusso","year":"2022","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib56","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/acschembio.2c00902","article-title":"Design of class I\/IV bromodomain-targeting degraders for chromatin remodeling complexes","volume":"18","author":"Zahid","year":"2023","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.apsb.2025.08.006_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1021\/acs.jmedchem.1c01864","article-title":"Design, synthesis, and biological evaluation of 1-(indolizin-3-yl)ethan-1-ones as CBP bromodomain inhibitors for the treatment of prostate cancer","volume":"65","author":"Xiang","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib58","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1021\/acs.jmedchem.0c00075","article-title":"Application of atypical acetyl-lysine methyl mimetics in the development of selective inhibitors of the bromodomain-containing protein 7 (BRD7)\/bromodomain-containing protein 9 (BRD9) bromodomains","volume":"63","author":"Clegg","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib59","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1021\/acs.jmedchem.2c00100","article-title":"Structure-based discovery and optimization of furo[3,2-c]pyridin-4(5H)-one derivatives as potent and second bromodomain (BD2)-selective bromo and extra terminal domain (BET) inhibitors","volume":"65","author":"Li","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.08.006_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114311","article-title":"Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24\/BRPF1 bromodomain inhibitors","volume":"236","author":"Xiang","year":"2022","journal-title":"Eur J Med Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525005544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525005544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:34:22Z","timestamp":1772897662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525005544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2211383525005544"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.08.006","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key imidazolyl groups that induce phenylalanine flipping enhance the efficacy of oral BRD9 inhibitors for AML treatment","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}